What Biological Products: General; and Licensing requires
The FDA 21 CFR Parts 600-601 regulation requires manufacturers of biological products to submit a Biologics License Application (BLA) and comply with lot release testing and approval…
This is a preview. The full record adds the complete summary, 10 workflow steps, 6 schema fields and 6 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: U.S. Food and Drug Administration · Version: 1.0.1 · Last updated:
Primary source: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-600
SHA-256 integrity: f17d0c9e979b054269355a271273a0787c72b7d49a43a981da6971d274384994
Primary Citations — 6 traced to source
- 21 CFR Part 600, Section 600.3 - Lot Release Requirements
- 21 CFR Part 601, Section 601.2 - Biologics License Application
+ 4 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/fda-21-cfr-part-600-601-biologics-licensing.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/fda-21-cfr-part-600-601-biologics-licensing.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/fda-21-cfr-part-600-601-biologics-licensing
- Back to registry: Browse all 10,102 compliance nodes